These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

75 related articles for article (PubMed ID: 16944664)

  • 21. Infliximab drug and infusion costs among patients with Crohn's disease in a commercially-insured setting.
    Ollendorf DA; Lidsky L
    Am J Ther; 2006; 13(6):502-6. PubMed ID: 17122530
    [TBL] [Abstract][Full Text] [Related]  

  • 22. The impact of generic substitution on price competition in Finland.
    Aalto-Setälä V
    Eur J Health Econ; 2008 May; 9(2):185-91. PubMed ID: 17508226
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Chronic catastrophes: exploring the concentration and sustained nature of ambulatory prescription drug expenditures in the population of British Columbia, Canada.
    Hanley GE; Morgan S
    Soc Sci Med; 2009 Mar; 68(5):919-24. PubMed ID: 19135288
    [TBL] [Abstract][Full Text] [Related]  

  • 24. [The generics reform lowered drug prices].
    Lundin D; Jacob J; Engström A
    Lakartidningen; 2007 Feb 28-Mar 6; 104(9):680-1. PubMed ID: 17393865
    [No Abstract]   [Full Text] [Related]  

  • 25. Dispensing pattern of generic and brand-name drugs in children.
    Chen AY; Wu S
    Ambul Pediatr; 2008; 8(3):189-94. PubMed ID: 18501866
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Rising drug costs prompt new uses for old pills.
    Opar A
    Nat Med; 2006 Dec; 12(12):1333. PubMed ID: 17151672
    [No Abstract]   [Full Text] [Related]  

  • 27. Utilization, price, and spending trends for antidepressants in the US Medicaid Program.
    Chen Y; Kelton CM; Jing Y; Guo JJ; Li X; Patel NC
    Res Social Adm Pharm; 2008 Sep; 4(3):244-57. PubMed ID: 18794035
    [TBL] [Abstract][Full Text] [Related]  

  • 28. On macroeconomic characteristics of pharmaceutical generics and the potential for manufacturing and consumption under fuzzy conditions.
    Gascón F; de la Fuente D; Puente J; Lozano J
    Artif Intell Med; 2007 Nov; 41(3):223-35. PubMed ID: 17719212
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Analysis of national annual variation in total patient out-of-pocket Medicare Part D stand-alone prescription drug plan costs from 2007 to 2008.
    Walberg MP; Patel RA; Amaral MM
    J Med Econ; 2008; 11(4):625-37. PubMed ID: 19450072
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Unintentional poisoning deaths--United States, 1999-2004.
    Centers for Disease Control and Prevention (CDC)
    MMWR Morb Mortal Wkly Rep; 2007 Feb; 56(5):93-6. PubMed ID: 17287712
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Outcomes, utilization, and costs among thalassemia and sickle cell disease patients receiving deferoxamine therapy in the United States.
    Delea TE; Hagiwara M; Thomas SK; Baladi JF; Phatak PD; Coates TD
    Am J Hematol; 2008 Apr; 83(4):263-70. PubMed ID: 17924547
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Trend in prescription rates of drugs suspected to induce haematopoietic disorders in a population in Nagoya.
    Okada H; Ohno Y; Aoki K; Kuroishi T
    Nagoya J Med Sci; 1980 Nov; 43(1-2):29-39. PubMed ID: 7254310
    [No Abstract]   [Full Text] [Related]  

  • 33. Increasing generic drug use in Medicare Part D: the role of government.
    Kohl H; Shrank WH
    J Am Geriatr Soc; 2007 Jul; 55(7):1106-9. PubMed ID: 17608887
    [No Abstract]   [Full Text] [Related]  

  • 34. Substituting generic drugs: state roles.
    Cauchi R
    NCSL Legisbrief; 2009; 17(25):1-2. PubMed ID: 19526654
    [No Abstract]   [Full Text] [Related]  

  • 35. Use of generic cardiovascular medications by elderly Medicare beneficiaries receiving generalist or cardiologist care.
    Federman AD; Halm EA; Siu AL
    Med Care; 2007 Feb; 45(2):109-15. PubMed ID: 17224772
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Economic benefits of increased diagnosis of celiac disease in a national managed care population in the United States.
    Green PH; Neugut AI; Naiyer AJ; Edwards ZC; Gabinelle S; Chinburapa V
    J Insur Med; 2008; 40(3-4):218-28. PubMed ID: 19317331
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Generic drugs--safe, effective, and affordable.
    Peters JR; Hixon DR; Conner DP; Davit BM; Catterson DM; Parise CM
    Dermatol Ther; 2009; 22(3):229-40. PubMed ID: 19453347
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Anthropometrically derived dosing and drug costing calculations for treating visceral leishmaniasis in Bihar, India.
    Olliaro P; Sundar S
    Trop Med Int Health; 2009 Jan; 14(1):88-92. PubMed ID: 19121150
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Changes in drug prescription over a decade in an Arctic child population.
    Niclasen BV
    Acta Paediatr; 2006 Nov; 95(11):1456-60. PubMed ID: 17062477
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Drug prescribing pattern and disease pattern in KMC Duwakot Health Center.
    Bajracharya S; Pandey S; Shakya YL
    Kathmandu Univ Med J (KUMJ); 2004; 2(1):35-42. PubMed ID: 19780286
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 4.